CD274 and head and neck squamous cell carcinoma: The use of additional HNSCC models to corroborate these findings and further characterize the therapeutic potential of dual PI3Kγ and PD-L1 pathway inhibition and associated immunological mechanisms will facilitate translational application of this treatment modality.